Biolase, Inc. ( BIOL) - Stock Earnings
Stock symbol BIOL is outdated, potentially delisted? Maybe it is available on other exchange?
BIOL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.6 million USD | 10.9 million USD |
| 2023Q4 | -5.3 million USD | 13.5 million USD |
| 2024Q1 | -6.5 million USD | 10.1 million USD |
BIOL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -16.2 million USD | 39.2 million USD |
| 2022 | -28.6 million USD | 48.5 million USD |
| 2023 | -20.6 million USD | 49.2 million USD |
BIOL
Price: $0.02
52 week price:
Payout Ratio Range:
Earnings Per Share: 16.18 USD
P/E Ratio: 0.00
Exchange: OQB
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 574700
Ebitda: -14.7 millionMarket Capitalization: 453804